Showing results (91-100 of 99) with videos related to

Sort By:
Pageof 10
You have reached the last page of results.This site can display upto 99 results.
The Journal of Urology|May 1, 1996
Clinical diagnosis of bladder outlet obstruction in patients with benign prostatic enlargement and lower urinary tract symptoms: development and urodynamic validation of a clinical prostate score for the objective diagnosis of bladder outlet obstructionP F Rosier, M J de Wildt, H Wijkstra, et al.
Actas Urologicas Espanolas|June 14, 2001
[The future of urology in Europe: a perspective from the European Urology Association]R Vela Navarrete, J T Andersen, A Borowka, et al.
European Urology|April 18, 2001
The future of urology in Europe: an overview from the European association of urologyR Vela Navarrete, J T Andersen, A Borowka, et al.
B-ENT|February 10, 2011
Antibiotic use and doctor visits are reduced after adenotonsillectomyN Lemkens, P Lemkens, T W Egondi, et al.
Cancer|September 1, 1990
Some limitations of the radioisotope bone scan in patients with metastatic prostatic cancer. A subanalysis of EORTC trial 30853. The EORTC Urological GroupP H Smith, A Bono, F Calais da Silva, et al.
The Journal of Urology|August 1, 1997
Adjuvant chemotherapy for superficial transitional cell bladder carcinoma: long-term results of a European Organization for Research and Treatment of Cancer randomized trial comparing doxorubicin, ethoglucid and transurethral resection aloneK Kurth, U Tunn, R Ay, et al.
The Journal of Urology|May 1, 1995
The prediction of clinical outcome from transurethral microwave thermotherapy by pressure-flow analysis: a European multicenter studyA Tubaro, S S Carter, J de la Rosette, et al.
The Journal of Urology|August 1, 1984
Adjuvant chemotherapy of superficial transitional cell bladder carcinoma: preliminary results of a European organization for research on treatment of cancer. Randomized trial comparing doxorubicin hydrochloride, ethoglucid and transurethral resection aloneK H Kurth, F H Schröder, U Tunn, et al.
Urology|April 1, 1997
Evaluation and follow-up of patients with N1-3 M0 or NXM1 prostate cancer in phase III trialsR Hall, P O Hedlund, R Ackermann, et al.
Pageof 10